Abstract
No public abstract is available from the verified source records.
Jonathan D. Schoenfeld, Wai Tong Ng, Claire Paterson, Lachlan McDowell
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
10.2139/ssrn.4996826
10.2139/ssrn.4996826
Nivolumab added to cisplatin and radiotherapy versus cisplatin and radiotherapy alone after surgery for people with squamous cell carcinoma of the head and neck at a high risk of relapse (GORTEC 2018-01 NIVOPOST-OP): A randomised, open-label, phase 3 trial
10.1016/s0140-6736(25)01850-1 · 2026
Proton beam therapy for oropharyngeal cancer (TORPEdO): A phase 3, randomised controlled trial
10.1016/s0140-6736(26)00314-4 · 2026
Proton versus photon radiotherapy for patients with oropharyngeal cancer in the USA: A multicentre, randomised, open-label, non-inferiority phase 3 trial
10.1016/s0140-6736(25)01962-2 · 2026
Neoadjuvant and adjuvant pembrolizumab in locally advanced head and neck cancer
10.1056/nejmoa2415434 · 2025
Primary chemotherapy in resectable oral cavity squamous cell cancer: A randomized controlled trial
10.1200/jco.2003.06.146 · 2003
Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma
10.1200/jco.2012.43.8820 · 2013
Unresolved referenced work
Kept as external metadata until matched
Neoadjuvant-adjuvant or adjuvant-only pembrolizumab in advanced melanoma
10.1056/nejmoa2211437 · 2023
No additional external references are available.